Compounds > bromocriptine
Page last updated: 2024-08-23

bromocriptine and Sleep Wake Disorders

bromocriptine has been researched along with Sleep Wake Disorders in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Audebert, C; Blin, O; Eusebio, A; Jouve, E; Micallef, J; Rey, M; Rouby, F; Tardieu, S1
Han, SY; Ratnagopal, P; Tan, EK; Wong, MC1
Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, N1
Emrich, D; Hajak, G; Kögler, A; Munz, DL; Riemann, H; Rüther, E; Staedt, J; Stoppe, G1

Trials

4 trial(s) available for bromocriptine and Sleep Wake Disorders

ArticleYear
Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.
    British journal of clinical pharmacology, 2009, Volume: 67, Issue:3

    Topics: Adolescent; Adult; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cross-Over Studies; Double-Blind Method; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Pramipexole; Sleep Wake Disorders; Treatment Outcome; Young Adult

2009
Piribedil and bromocriptine in Parkinson's disease: a single-blind crossover study.
    Acta neurologica Scandinavica, 2003, Volume: 107, Issue:3

    Topics: Administration, Oral; Aged; Antiparkinson Agents; Bromocriptine; Cross-Over Studies; Female; Hallucinations; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Piribedil; Psychomotor Agitation; Severity of Illness Index; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome

2003
Pergolide in late-stage Parkinson disease.
    Annals of neurology, 1982, Volume: 12, Issue:3

    Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Sleep Wake Disorders

1982
Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS).
    Journal of neural transmission. General section, 1995, Volume: 99, Issue:1-3

    Topics: Aged; Benzamides; Brain; Brain Chemistry; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Myoclonus; Polysomnography; Pyrrolidines; Receptors, Dopamine D2; Sleep Wake Disorders; Tomography, Emission-Computed, Single-Photon

1995